跳至主要内容
临床试验/TCTR20200710005
TCTR20200710005已完成2 期

Prospective, open-label study of progesterone to manage seizure in Drug resistant epilepsy

Department of Pharmacy, Faculty of pharmacy, Silpakorn university0 个研究点目标入组 19 人开始时间: 2020年7月10日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
19

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Lennox-Gastaut syndrome diagnosis
  • - 12 years and older
  • - at least 2 antiepileptic drugs treatment (each at least 2 weeks)
  • - seizure frequency more than 5 times per month for more than 1 year
  • - learning or mental retardation

排除标准

  • - do not have caregiver
  • - not cooperated
  • - pregnancy
  • - during any hormone treatment
  • - CHA2DS2-VASc at least 3 scores
  • - history of stroke or myocardial infarction in 1 year
  • - AST/ALT elevation 3 folds or more from upper limit of normal (ULN) in 3 months
  • - abnormal renal function eGFR less than 30 mL/min
  • - during penicillins treatment
  • - any cancer diagnosis
  • - progesterone allergy
  • - any history of uncommon vaginal bleeding

研究者

发起方
Department of Pharmacy, Faculty of pharmacy, Silpakorn university

相似试验

The pharmacokinetic study of progesterone and... | 临床试验